Price Alert

CBIZ Inc. (CBZ)

NYSE: CBZ · Real-Time Price · USD

62.38

0.01 (0.02%)

At close: Aug 18, 2025, 3:59 PM

62.45

0.11%

After-hours: Aug 18, 2025, 06:09 PM EDT

0.02% (1D)

Bid	62.11
Market Cap	3.37B
Revenue (ttm)	2.42B
Net Income (ttm)	109.08M
EPS (ttm)	1.44
PE Ratio (ttm)	43.32
Forward PE	15.49
Analyst	Buy

Ask	66.66
Volume	345,497
Avg. Volume (20D)	594,988
Open	62.44
Previous Close	62.37
Day's Range	62.16 - 62.83
52-Week Range	56.83 - 90.13
Beta	0.92

About CBZ

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CBZ

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CBZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

CBIZ Inc. is scheduled to release its earnings on Oct 28, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

-19.74%

CBIZ shares are trading lower after the company re... Unlock content with Pro Subscription

2 months ago

+5.28%

Shares of companies within the broader industrial sector are trading higher, possibly amid overall market strength after President Trump delayed 50% EU tariffs to July.

News

2 weeks ago · fool.com

CBIZ (CBZ) Q2 EPS Jumps 64%

2 weeks ago · seekingalpha.com

CBIZ, Inc. (CBZ) Q2 2025 Earnings Call Transcript

CBIZ, Inc. (NYSE:CBZ ) Q2 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Brad S. Lakhia - Senior VP & CFO Jerome P.

2 weeks ago · zacks.com

CBIZ (CBZ) Surpasses Q2 Earnings Estimates

CBIZ (CBZ) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.5 per share a year ago.

1 month ago · seekingalpha.com

CBIZ: Price Per Share Appreciation Will Continue - Strong Buy

CBIZ's successful Marcum acquisition drove strong operating cash flow and stock price gains, highlighting effective integration and economies of scale. Despite a temporary dip in operating income and ...

1 month ago · zacks.com

3 Resilient Consulting Stocks to Consider Amid Industry Woes

Geopolitical tensions, tariff concerns, and slowdown fears through 2026 are weighing on the consulting industry. However, strong demand for AI-driven transformation and corporate cost-cutting efforts ...

1 month ago · businesswire.com

Construction Sector Holds Steady: CBIZ Survey Shows Firms Balancing Caution with Commitment to Growth

CLEVELAND--(BUSINESS WIRE)--Construction Sector Holds Steady: CBIZ Survey Shows Firms Balancing Caution with Commitment to Growth.

2 months ago · businesswire.com

CBIZ, Inc. Appoints Seth Goldblum as National Leader of Advisory Services

CLEVELAND--(BUSINESS WIRE)--CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, today announced that it has appointed Seth Goldblum as National Leader of Advisory Services, effec...

2 months ago · newsfilecorp.com

InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA

Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of propri...

3 months ago · businesswire.com

CBIZ Report Highlights Rising Costs: Surge in Inpatient and Outpatient Expenses, Popular GLP-1 Drugs like Ozempic Drive Pharmacy Spend Increase

CLEVELAND--(BUSINESS WIRE)--CBIZ, Inc. (NYSE: CBZ), a leading national professional services advisor, announced the release of its 2025 State of Healthcare Report. The report provides a data-driven lo...